Ovarian Cancer : Scientific References

Aktas D, Guney I, Alikasifoglu M, Yuce K, Tuncbilek E, Ayhan A. 2002. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Gynecol Oncol 86:124-128.

Bertone ER, Newcomb PA, Willett WC, Stampfer MJ, Egan KM. 2002. Recreational physical activity and ovarian cancer in a population-based case-control study. Int J Cancer 99:431-436.

Bertone ER, Willett WC, Rosner BA, Hunter DJ, Fuchs CS, Speizer FE, Colditz GA, Hankinson SE. 2001. Prospective study of recreational physical activity and ovarian cancer. J Natl Cancer Inst 93:942-948.

Chang S, Risch HA. 1997. Perineal talc exposure and risk of ovarian carcinoma. Cancer 79:2396-2401.

Cottreau CM, Ness RB, Kriska AM. 2000. Physical activity and reduced risk of ovarian cancer. Obstet Gynecol 96:609-614,

Cramer DW, Liberman RF, Titus-Ernstoff L, Welch WR, Greenberg ER, Baron JA, Harlow BL. 1999. Genital talc exposure and risk of ovarian cancer. Int J Cancer 81: 351-356.

Daly M, Obrams GI. 1998. Epidemiology and risk assessment for ovarian cancer. Semin Oncol 25:255-264.

Donna A, Betta PG, Robutti F, Crosignani P, Berrino F, Bellingeri D. 1984. Ovarian mesothelial tumors and herbicides: a case-control study. Carcinogenesis 5: 941-2,

Donna A, Crosignani P, Robutti F, Betta PG, Bocca R, Mariani N, Ferrario F, Fissi R, Berrino F. 1989. Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health 15: 47-53.

Egli GE, Newton M. 1961. The transport of carbon particles in the human female reproductive tract. Fertil Steril 12:151-155.

Freedman DM, Dosemeci M, McGlynn K. 2002. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med. 59(4):257-62,

Gertig DM, Hunter DJ, Cramer DW, Colditz GA, Speizer FE, Willett WC, Hankinson SE. 2000. Prospective study of talc use and ovarian cancer. J Natl Cancer Inst 92:249-252.

Gojermac T, Kartal B, Zuric M, Kusevic S, Cvetnic Z. 1996. Serum biochemical changes associated with cystic ovarian degeneration in pigs after atrazine treatment. Toxical Letters 85(1):9-15.

Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, et al. 2001. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epid Biomark Prev 10:209-216.

Harlap S, Olson S, Akhmedkhanov A, Barakat RR, Caputo T, Sanchez D, Xue X. 2001. Epithelial ovarian carcinoma and European birthplace of grandparents. Gynecol Oncol 81:25-32.

Henderson WJ, Joslin CAF, Turnbull AC, Griffiths K. 1971. Talc and carcinoma of the ovary and cervix. J Obstet Gynecol Br Commonw 78:266-272.

Huncharek M, Geschwind JF, Kupelnick B. 2003. Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies. Anticancer Res. 23(2C):1955-60.

John EM, Whittemore AS, Harris R, Itnyre J, et al. 1993. Characteristics relating to ovarian cancer risk: Collaborative analysis of seven U.S. case-control studies. V. Epithelial ovarian cancer in black women. J Natl Cancer Instit 85:142-147.

Keal EE. 1960. Asbestosis and abdominal neoplasms. Lancet 2: 1211-1216.

La Vecchia C. 2001. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev 10:125-129.

Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C. 2002. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334-341.

Lefkowitz ES, Garland CF. 1994. Sunlight, vitamin D, and ovarian cancer mortality rates in U.S. women. Int J Epidemiol 23:1133-1136.

Lubin F, Chetrit A, Freedman LS, Alfandary E, Fishler Y, Nitzan H, Zultan A, Modan B. 2003. Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 157:113-120.

Ozols RF, Schwartz PE, Eifel PJ. 1997. Ovarian Cancer, Fallopian Tube Carcinoma and Peritoneal Carcinoma. In: Cancer, Principles and Practice of Oncology, Vol 1. 5th Edition. DeVita VT Jr., Hellman S, Rosenberg SA (eds). Lippincott-Raven Publishers, Philadelphia. p 1502-3.

Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Weiderpass E, Persson IR. 2002. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 94:497-504.

Sala M, Dosemeci M, Zahm SH. 1998. A death certificate-based study of occupation and mortality from reproductive cancers among women in 24 U.S. states. J Occup Environ Med 40:632-639.

Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez Lira-Lira G, Escudero-De los Rios P, Hernandez-Avila M. 2002. Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology 63:151-157.

Shen N, Weiderpass E, Antilla A, Goldberg MS, Vasama-Neuvonen KM, Boffetta P, et al. 1998. Epidemiology of occupational and environmental risk factors related to ovarian cancer. Scand J Work Environ Health 24:175-182.

Shields T, Gridley G, Moradi T, Adami J, Plato N, Dosemeci M. 2002. Occupational exposures and the risk of ovarian cancer in Sweden. Am J Indust Med 42: 200-213.

Tavani A, Gallus S, La Vecchia C, Dal Maso L, Negri E, Pelucchi C, et al. 2001. Physical activity and risk of ovarian cancer: an Italian case-control study. Int J Cancer 91:407-411.

Tortolero-Luna G, Mitchell MF. 1995. The epidemiology of ovarian cancer. J Cell Biochem Suppl 23:200-207.

Wehner AP. 2002. Cosmetic talc should not be listed as a carcinogen: comments on NTP's deliberations to list talc as a carcinogen. Regul Toxicol Pharmacol 36(1):40-50.

Whittemore AS, Harris R, Itnyre J, et al. 1992. Characteristics relating to ovarian cancer risk: Collaborative analysis of twelve U.S. case-control studies. II Invasive epithelial ovarian cancers in white women. Am J Epidemiol 136:1184-1203.

Whittemore AS. 1994. Characteristics relating to ovarian cancer risk: Implications for prevention and detection. Gynecol Oncol 55:S15-S19.